M
Mark H. Yazer
Researcher at University of Pittsburgh
Publications - 298
Citations - 6979
Mark H. Yazer is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Blood transfusion. The author has an hindex of 38, co-authored 264 publications receiving 5315 citations. Previous affiliations of Mark H. Yazer include University of Copenhagen & Odense University Hospital.
Papers
More filters
Journal ArticleDOI
Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock.
Jason L. Sperry,Francis X. Guyette,Joshua B. Brown,Mark H. Yazer,Darrell J. Triulzi,Barbara J. Early-Young,Peter W. Adams,Brian J. Daley,Richard S. Miller,Brian G. Harbrecht,Jeffrey A. Claridge,Herb A. Phelan,William R. Witham,A. Tyler Putnam,Therese M. Duane,Louis H. Alarcon,Clifton W. Callaway,Brian S. Zuckerbraun,Matthew D. Neal,Matthew R. Rosengart,Raquel M. Forsythe,Timothy R. Billiar,Donald M. Yealy,Andrew B. Peitzman,Mazen S. Zenati +24 more
TL;DR: In injured patients at risk for hemorrhagic shock, the prehospital administration of thawed plasma was safe and resulted in lower 30‐day mortality and a lower median prothrombin‐time ratio than standard‐care resuscitation.
Journal ArticleDOI
Transfusion reactions: prevention, diagnosis, and treatment.
Meghan Delaney,Silvano Wendel,Rachel S. Bercovitz,Joan Cid,Claudia S. Cohn,Nancy M. Dunbar,Torunn Oveland Apelseth,Mark A. Popovsky,Simon J. Stanworth,Simon J. Stanworth,Alan Tinmouth,Alan Tinmouth,Leo M.G. van de Watering,Jonathan H. Waters,Mark H. Yazer,Alyssa Ziman +15 more
TL;DR: An international panel of experts provides a synopsis of the pathophysiology, treatment, and management of each diagnostic category of transfusion reaction using evidence-based recommendations whenever available.
Journal ArticleDOI
Transfusion-associated circulatory overload after plasma transfusion.
TL;DR: The rate of TACO caused by plasma transfusion was sought to determine to determine the rate of transfusion-related mortality reported to the Food and Drug Administration.
Journal ArticleDOI
Whole blood for hemostatic resuscitation of major bleeding.
Philip C. Spinella,Heather F. Pidcoke,Geir Strandenes,Tor Hervig,Andrew D Fisher,Donald H. Jenkins,Mark H. Yazer,James R. Stubbs,Alan D. Murdock,Anne Sailliol,Paul M. Ness,Andrew P. Cap +11 more
TL;DR: US Army data indicate that WB transfusion is associated with improved or comparable survival compared to resuscitation with blood components, and indicate that platelet (PLT)‐containing blood products stored at 4°C have superior hemostatic function, based on reduced bleeding and improved functional measures of hemostasis.